Treatment of murine Candida krusei or Candida glabrata infection with L-743,872.
L-743,872 is a broad-spectrum pneumocandin antifungal drug developed by Merck Research Co., and in the present work it was evaluated in vivo in murine models of Candida krusei and Candida glabrata infection. Mice were infected intravenously with two isolates of C. krusei and treated with fluconazole...
Na minha lista:
| 發表在: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology (ASM)
1997
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164039/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9303388/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.9.1937 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|